Open Access<p>Emodin Reverses the Epithelial–Mesenchymal Transition of Human Endometrial Stromal Cells by Inhibiting ILK/GSK-3β Pathway</p>
Author(s) -
Qiaomei Zheng,
Jinhua Wang,
Wenwen Li,
Xiaoyun Chen,
Shaozhan Chen,
Lihong Chen
Publication year - 2020
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
ISSN - 1177-8881
DOI - 10.2147/dddt.s262816
Subject(s) - emodin , stromal cell , epithelial–mesenchymal transition , vimentin , cancer research , chemistry , gene silencing , gentamicin protection assay , endometriosis , biology , western blot , microbiology and biotechnology , medicine , downregulation and upregulation , immunohistochemistry , gene , biochemistry
To explore the exact mechanism through which emodin down-regulates the migration and invasion abilities of endometrial stromal cells. Moreover, to explore the theoretical basis of emodin in the treatment of endometriosis.